Clincosm LogoSign in Get a demo

Asthma

Showing NaN - NaN of 172
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Protocol CAUSE-03 / CHEETAH

Not yet recruiting
  • Asthma
    • Aurora, Colorado
    • +6 more
    Nov 15, 2023

    Asthma Trial in Worldwide (BGF MDI 320/28.8/9.6 µg, BGF MDI 320/14.4/9.6 µg, BFF MDI 320/9.6 µg)

    Recruiting
    • Asthma
    • BGF MDI 320/28.8/9.6 μg
    • +3 more
    • Birmingham, Alabama
    • +423 more
    Jan 18, 2023

    Asthma Trial in Worldwide (DUPIXENT®)

    Recruiting
    • Asthma
    • Birmingham, Alabama
    • +123 more
    Jan 13, 2023

    Asthma Trial in Canada, United States (TEV-53275 Dose A, TEV-53275 Dose B, Placebo)

    Terminated
    • Asthma
    • TEV-53275 Dose A
    • +2 more
    • Hoover, Alabama
    • +81 more
    Dec 27, 2022

    Observational Study of Obstructive Lung Disease (NOVELTY)

    Active, not recruiting
    • Asthma
    • +2 more
    • Blood draw
    • +3 more
    • Loma Linda, California
    • +302 more
    Nov 22, 2022

    Asthma Trial in United States (Budesonide/Formoterol fumarate dihydrate, Symbicort, Placebo)

    Completed
    Has Results
    • Asthma
    • Budesonide/Formoterol fumarate dihydrate
    • +2 more
    • Birmingham, Alabama
    • +94 more
    Aug 1, 2022

    Asthma Trial in Worldwide (BFF MDI 320/9.6 µg, BFF MDI 160/9.6 µg, BD MDI 320 µg)

    Recruiting
    • Asthma
    • BFF MDI 320/9.6 μg
    • +3 more
    • Saraland, Alabama
    • +121 more
    Aug 22, 2022

    Asthma Trial in Tampa, Chevy Chase, Cincinnati (ARS-1, Albuterol MDI, Placebo)

    Recruiting
    • Asthma
    • Tampa, Florida
    • +2 more
    Aug 10, 2022

    Asthma Trial in United States (Tezepelumab)

    Recruiting
    • Asthma
    • Mobile, Alabama
    • +28 more
    Aug 2, 2022

    Asthma Trial in United States (Mepolizumab, Placebo)

    Completed
    Has Results
    • Asthma
    • Mepolizumab
    • Placebo
    • Aurora, Colorado
    • +8 more
    Jun 23, 2022

    Asthma Trial in United States (Fluticasone propionate/salmeterol (FS), Albuterol, Standard of Care Asthma Medication)

    Completed
    • Asthma
    • Fluticasone propionate/salmeterol (FS)
    • +3 more
    • Phoenix, Arizona
    • +45 more
    Jul 15, 2022

    Chronic Rhinosinusitis With Nasal Polyps, Asthma Trial in Worldwide (Dupilumab, Omalizumab, Placebo)

    Recruiting
    • Chronic Rhinosinusitis With Nasal Polyps
    • Asthma
    • Tucson, Arizona
    • +65 more
    Jul 12, 2022

    Asthma Trial in United States (Dupilumab, Placebo)

    Recruiting
    • Asthma
    • Aurora, Colorado
    • +6 more
    Jun 1, 2022

    Asthma Trial in United States

    Recruiting
    • Asthma
      • Aurora, Colorado
      • +6 more
      Jun 1, 2022

      Asthma, Wheezing Trial in United States (Azithromycin, Placebo)

      Recruiting
      • Asthma
      • Wheezing
      • Atlanta, Georgia
      • +5 more
      Apr 29, 2022

      Asthma Trial in Worldwide (Dupilumab, Placebo, Asthma Controller Therapies)

      Completed
      Has Results
      • Asthma
      • Birmingham, Alabama
      • +98 more
      Mar 15, 2022

      Asthma Trial in Worldwide (Dupilumab)

      Completed
      Has Results
      • Asthma
      • Birmingham, Alabama
      • +364 more
      Mar 21, 2022

      Eosinophilic Asthma, Asthma Trial in United States (Dexpramipexole, Placebo)

      Completed
      Has Results
      • Eosinophilic Asthma
      • Asthma
      • Los Angeles, California
      • +35 more
      Feb 25, 2022

      Asthma Trial in Cincinnati (Technology-assisted Stepped-care)

      Completed
      • Asthma
      • Technology-assisted Stepped-care
      • Cincinnati, Ohio
        Cincinnati Children's Medical Hospital
      Mar 9, 2022

      Asthma Trial in Worldwide (Placebo, Brodalumab)

      Terminated
      Has Results
      • Asthma
      • Placebo
      • Brodalumab
      • Birmingham, Alabama
      • +160 more
      Feb 3, 2022

      Asthma Trial in United States (MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate), Advair (Fixed

      Completed
      Has Results
      • Asthma
      • MGR001 (Fixed dose combination of Fluticasone propionate and salmeterol xinafoate)
      • +2 more
      • Birmingham, Alabama
      • +100 more
      Feb 22, 2022

      Asthma Trial in United States (Omalizumab, Placebo)

      Recruiting
      • Asthma
      • Phoenix, Arizona
      • +12 more
      Jan 13, 2022

      Asthma Trial in Worldwide (GSK3511294 (Depemokimab), Placebo)

      Recruiting
      • Asthma
      • GSK3511294 (Depemokimab)
      • Placebo
      • Alabaster, Alabama
      • +99 more
      Dec 29, 2021

      Asthma Trial in United States (CHF 718 pMDI, Placebo pMDI, Beclomethasone Dipropionate (BDP))

      Completed
      Has Results
      • Asthma
      • CHF 718 pMDI
      • +2 more
      • Birmingham, Alabama
      • +133 more
      Dec 13, 2021

      Asthma Trial in Worldwide (Tezepelumab, Placebo)

      Completed
      Has Results
      • Asthma
      • Tezepelumab
      • Placebo
      • Bakersfield, California
      • +59 more
      Nov 10, 2021